孕期糖尿病的风险估计 孕期糖尿病在第一季度
Dóra Gerszi1,2, Gergő Orosz3, Marianna Török1,4
1Department of Obstetrics and Gynecology, Faculty of Medicine, Semmelweis University, Budapest H-1082, Hungary.
The Journal of clinical endocrinology and metabolism
|May 29, 2023
概括
早期预测孕期糖尿病 (GDM) 是可能使用第一季度的生物标志物. 这允许及时干预,以预防并发症并减少母亲和儿童的长期代谢风险.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 代谢性疾病研究研究.
- 发现生物标志物的发现.
背景情况:
- 没有可靠的第一季度风险估计可用于预测妊娠糖尿病 (GDM).
- 早期GDM检测对于预防妊娠并发症至关重要.
- 及时干预可以减轻长期的代谢风险.
研究的目的:
- 为了确定早期,第一季度GDM的预测标记.
- 开发一个预测模型,以后开始的GDM.
主要方法:
- 使用匈牙利生物银行队列 (2545名孕妇) 的病例控制研究.
- 来自55名GDM和55名对照女性的血清/血样本分析了氧化-酸性压力,激素和代谢物.
- 前进渐进的多变量逻辑回归用于构建预测模型.
主要成果:
- 患有GDM的女性年龄较大,BMI较高.
- 观察到高水平的果糖胺,总抗氧化能力,丸激素,皮质素和21-脱氧皮质醇.
- 发现了较低水平的可溶性泌尿酶等离子激素激活体受体 (SuPAR),脱二二硫酸,二二,皮质醇和11-脱氧皮质.
- 一个GDM预测模型使用果糖胺,皮质醇,皮质素,11-脱氧皮质和SuPAR实现了96.6%的特异性和97.5%的敏感性.
结论:
- 准确的预测GDM是可行的在怀孕的第一季度.
- 早期风险估计可以实现有针对性的预防和及时治疗.
- 预防GDM可以降低母亲和后代的终身代谢风险.
更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes: Symptoms, Diagnosis, and Complications
606
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
Insulin: Dosing Regimen and Adverse Effects
217
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
217


